Opportunity Information: Apply for RFA GH 13 001
Apply for RFA GH 13 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 19, 2012 and posted on Dec 18, 2012.
- Applicants must submit their applications by Feb 22, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $20,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Special Eligibility Requirements Eligibility for this program is limited to any academic institution in metropolitan area of Guatemala City that meets the criteria briefly described below. This special requirement for eligibility is based on the key objectives of the programs to develop and implement disease research projects, and allow the organization to carry out multiple, ongoing, public health research activities in Guatemala and the Central American region. A biosafety level laboratory (BSL 2) in Guatemala that is uniquely equipped to carry out these actions and provide laboratory capacity and support to the Ministry of Health in Guatemala and other countries in the region collaborating with Central American Council of Ministers of Health (COMISCA). Have the legal authority to hire third country nationals with the technical skills to meet the requirements of the proposed research components through an expedited process and unique capability to bolster research capacity in Guatemala and the region. Established history of collaboration with CDC and the Guatemalan Ministry of Health and COMISCA.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region opportunity (Funding Opportunity Number RFA GH 13 001) was a CDC discretionary grant offered as a cooperative agreement under CFDA 93.283 (Centers for Disease Control and Prevention Investigations and Technical Assistance). Posted on December 18, 2012 and closing on February 22, 2013 (archived March 24, 2013), it was designed to support a single award focused on building and sustaining applied public health research capacity in Guatemala, with benefits extending across the Central American region. The core idea behind the program was not simply to fund studies in isolation, but to create a durable platform for generating evidence and then using that evidence directly in disease prevention and control programs, while also sharing methods, findings, and expertise across neighboring countries.
At the heart of the project was a strong emphasis on conducting both field and laboratory research on diseases of major public health importance. The announcement highlights emerging and re-emerging infectious diseases as a priority, reflecting the ongoing need to detect outbreaks quickly, understand changing transmission patterns, and respond to evolving threats. At the same time, the scope was broad enough to include other clearly defined public health problems, meaning applicants could potentially address high-burden conditions beyond classic outbreak pathogens as long as the work was framed as actionable public health research. The expected approach combined real-world data collection in communities and health systems with laboratory-based investigation, creating an evidence pipeline that could connect surveillance signals and clinical observations to confirmatory testing, characterization of pathogens, and practical recommendations for prevention.
A defining feature of the opportunity was its focus on translating research into operations. The stated purpose explicitly calls for incorporating research results into disease prevention and control programs in Guatemala and the wider Central American region. In practice, that implies that research topics, study designs, and outputs were expected to align with public health decision-making needs, such as improving outbreak investigation practices, refining prevention strategies, strengthening laboratory and epidemiology workflows, and supporting ministries of health in planning and response. The announcement also stresses the importance of ensuring that expertise and research findings are shared with other nations, pointing to regional collaboration and knowledge transfer as a deliverable rather than an optional add-on. This regional emphasis is reinforced by the reference to COMISCA (the Central American Council of Ministers of Health), signaling that the program was intended to plug into existing regional health coordination structures.
The funding parameters indicate a substantial investment with flexibility across project needs. The estimated total funding listed is $4,000,000, while the award ceiling is shown as $20,000,000 and the floor as $0, and the program did not require cost sharing or matching. The cooperative agreement mechanism is also important because it typically means CDC anticipated substantial involvement in the project beyond standard grant oversight, such as collaboration on technical direction, alignment with public health priorities, and coordination with government counterparts. The listing notes that one award was expected, suggesting an intention to concentrate resources in a single institution capable of serving as a hub for multiple research activities rather than distributing smaller awards across many organizations.
Eligibility was highly specific and intentionally limited. Applicants had to be an academic institution located in the metropolitan area of Guatemala City and meet special requirements tied to the program goals. Those requirements included having a biosafety level 2 (BSL-2) laboratory in Guatemala that was uniquely equipped to support the proposed field and laboratory activities, including providing laboratory capacity and support to Guatemala's Ministry of Health and to other countries collaborating through COMISCA. The eligible institution also needed legal authority to hire third-country nationals through an expedited process, reflecting a practical need to rapidly bring in specialized technical skills to execute research components and strengthen capacity. In addition, the institution needed an established history of collaboration with CDC and with the Guatemalan Ministry of Health and COMISCA, which indicates CDC was looking for an applicant with proven relationships, trust, and operational experience in the national and regional public health landscape.
Overall, the opportunity can be read as an effort to strengthen a regional center of gravity for applied infectious disease research and public health action: building laboratory and field research capability, aligning studies with real prevention and control needs, and creating mechanisms for rapid dissemination of findings and expertise across Central America. Rather than framing research as an academic exercise, the announcement positions it as a tool for immediate public health use, with the expectation that the awardee would work closely with CDC, Guatemala's Ministry of Health, and regional partners to ensure that evidence generated in Guatemala could inform and improve programs both nationally and across the region.
For applicants or partners who needed help accessing the announcement at the time, the contact listed was the CDC Procurement and Grants Office Technical Information Management, reachable by phone at (770) 488-2700 or by email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
1) What is the name of this grant opportunity?
The opportunity is titled Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region.
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA GH 13 001.
3) Which federal agency offered this opportunity?
This was offered by the Centers for Disease Control and Prevention (CDC).
4) What type of funding mechanism was used?
It was a CDC discretionary grant offered as a cooperative agreement.
5) What CFDA program was this associated with?
This opportunity was under CFDA 93.283, described as Centers for Disease Control and Prevention Investigations and Technical Assistance.
6) When was the opportunity posted and when did it close?
It was posted on December 18, 2012 and closed on February 22, 2013.
7) Is this opportunity still open?
No. The listing indicates it was archived on March 24, 2013.
8) What was the overall purpose of the program?
The purpose was to build and sustain applied public health research capacity in Guatemala, while extending benefits across the Central American region. The program emphasized creating a durable platform that generates evidence and then uses that evidence directly in disease prevention and control programs, with active regional sharing of methods, findings, and expertise.
9) Was the goal to fund isolated research studies, or something broader?
Something broader. The core idea was not simply to fund studies in isolation, but to establish and sustain a long-term, applied research capacity that supports real public health action and regional knowledge transfer.
10) What kinds of research activities were emphasized?
The announcement emphasized conducting both field and laboratory research on diseases of major public health importance, connecting real-world data collection with laboratory investigation to support actionable prevention and control recommendations.
11) Which disease areas were highlighted as priorities?
The opportunity highlights emerging and re-emerging infectious diseases as a priority, reflecting the need for rapid detection, understanding of changing transmission patterns, and response to evolving threats.
12) Could applicants propose work outside emerging infectious diseases?
Yes. The scope is described as broad enough to include other clearly defined public health problems, as long as the work was framed as actionable public health research.
13) What does “translating research into operations” mean in this context?
It means research results were expected to be incorporated into disease prevention and control programs in Guatemala and across Central America. This implies alignment with public health decision-making needs, such as improving outbreak investigation practices, strengthening laboratory and epidemiology workflows, refining prevention strategies, and supporting planning and response.
14) Was regional collaboration required or optional?
The opportunity stresses that expertise and findings should be shared with other nations. The regional emphasis is presented as a deliverable rather than an optional add-on.
15) What regional body is referenced, and why does it matter?
The opportunity references COMISCA (the Central American Council of Ministers of Health), signaling that the program was intended to connect to existing regional health coordination structures and support collaboration across countries.
16) How many awards did CDC expect to make?
The listing notes that one award was expected.
17) What was the estimated total funding for the program?
The estimated total funding listed is $4,000,000.
18) What were the award ceiling and award floor?
The award ceiling is shown as $20,000,000 and the award floor is shown as $0.
19) Was cost sharing or matching required?
No. The program did not require cost sharing or matching.
20) What does it mean that this was a cooperative agreement?
The cooperative agreement mechanism typically indicates CDC anticipated substantial involvement beyond standard grant oversight, such as collaboration on technical direction, alignment with public health priorities, and coordination with government counterparts.
21) Who was eligible to apply?
Eligibility was intentionally limited. Applicants had to be an academic institution located in the metropolitan area of Guatemala City and meet specific special requirements tied to the program goals.
22) What laboratory capability was required for eligibility?
The applicant needed to have a biosafety level 2 (BSL-2) laboratory in Guatemala that was uniquely equipped to support the proposed field and laboratory activities.
23) Did the BSL-2 laboratory requirement include support for government and regional partners?
Yes. The laboratory was expected to provide capacity and support to Guatemala’s Ministry of Health and to other countries collaborating through COMISCA.
24) What hiring authority did the eligible institution need?
The eligible institution needed legal authority to hire third-country nationals through an expedited process, reflecting a practical need to bring in specialized technical skills quickly to execute research and strengthen capacity.
25) Were prior partnerships a requirement?
Yes. The eligible institution needed an established history of collaboration with CDC and with the Guatemalan Ministry of Health and COMISCA, indicating CDC was seeking an applicant with proven relationships and operational experience in national and regional public health work.
26) Where was the program primarily focused, and who else was intended to benefit?
The program was focused on building capacity in Guatemala, with intended benefits extending across the Central American region through dissemination of methods, findings, and expertise.
27) What was the overarching model CDC seemed to be funding?
The opportunity reads as an effort to strengthen a regional hub for applied infectious disease research and public health action: building laboratory and field research capability, aligning studies with real prevention and control needs, and creating mechanisms for rapid sharing across Central America.
28) Who was listed as the contact for technical information about the announcement?
The contact listed was the CDC Procurement and Grants Office Technical Information Management.
29) What were the phone number and email address provided for the contact?
Phone: (770) 488-2700
Email: pgotim@cdc.gov
Browse more opportunities from the same category: Health
Next opportunity: Improved Biomaterials for Urinary and Dialysis Catheters (STTR) (R41/R42)
Previous opportunity: Drug Discovery for Nervous System Disorders (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA GH 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA GH 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Monitoring and Evaluation of Malaria Control and Elimination Activities Apply for RFA GH 13 005 Funding Number: RFA GH 13 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Prevalence and Incidence of Inflammatory Bowel Disease Apply for RFA DP 13 001 Funding Number: RFA DP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| NIDCD Small Grant Program (R03) Apply for PAR 13 057 Funding Number: PAR 13 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Estimating the Costs of Supporting Primary Care Practice Transformation (R03) Apply for RFA HS 13 003 Funding Number: RFA HS 13 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| Strengthening Public Health and the Public Health Laboratory System of Cambodia under the Presidents Emergency Plan for AIDS Relief Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1305 Funding Number: CDC RFA GH13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantees Apply for HRSA 13 152 Funding Number: HRSA 13 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| R40 MCH Autism Intervention Research Apply for HRSA 13 195 Funding Number: HRSA 13 195 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the Presidents Em Apply for CDC RFA GH13 1303 Funding Number: CDC RFA GH13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Global Animal Human Interface Activities for Avian Influenza and other Zoonotic Diseases Apply for RFA CK 13 002 Funding Number: RFA CK 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region Apply for RFA IP 13 002 Funding Number: RFA IP 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142 Funding Number: HRSA 13 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304 Funding Number: CDC RFA GH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062 Funding Number: PAR 13 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001 Funding Number: CMS 1A1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065 Funding Number: PAR 13 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa Apply for RFA GH 13 002 Funding Number: RFA GH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,000,000 |
| Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001 Funding Number: HIEGE HG 12 001 Agency: Office of the National Coordinator Category: Health Funding Amount: $400,000 |
| Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061 Funding Number: PAR 13 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213 Funding Number: HRSA 13 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: $110,000 |
| Limited Competition Initiative to Maximize Research Education in Genomics (R25) Diversity Action Plan Apply for PAR 13 063 Funding Number: PAR 13 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.